Should every metastatic prostate cancer patient get germline testing?
Introduction and first vote
Date
08 Oct 2016Session
Should every metastatic prostate cancer patient get germline testing?Presenters
Rob BristowAuthors
R. BristowAuthor affiliations
- Radiation Medicine Program, Princess Margaret Cancer Centre, M5G2M9 - Toronto, ON/CA
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
Yes
Presenter: Elena Castro Marcos
Session: Should every metastatic prostate cancer patient get germline testing?
Resources:
Slides
Webcast
No
Presenter: Bertrand Tombal
Session: Should every metastatic prostate cancer patient get germline testing?
Resources:
Slides
Webcast
Second vote and conclusions
Presenter: Rob Bristow
Session: Should every metastatic prostate cancer patient get germline testing?
Resources:
Slides
Webcast